General Pharmaceuticals Limited

POWER SEARCH PRICING

SOLUTIONS

general pharmaceuticals limited Company Information

Company Number

05019416

Next Accounts

Jan 2026

Directors

Ziad Tokatly

Gloria Tokatly

Shareholders

mrs gloria tokatly

mr ziad tokatly

Group Structure

View All

Industry

Wholesale of pharmaceutical goods

Registered Address

32 woodstock grove, shepherds bush, london, W12 8LE

Website

www.generalpharma.com

general pharmaceuticals limited Estimated Valuation

£208.3k

Pomanda estimates the enterprise value of GENERAL PHARMACEUTICALS LIMITED at £208.3k based on a Turnover of £642k and 0.32x industry multiple (adjusted for size and gross margin).

Edit your figures and get a professional valuation report.

General Pharmaceuticals Limited is a live company located in london, W12 8LE with a Companies House number of 05019416. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in January 2004, it's largest shareholder is mrs gloria tokatly with a 50% stake. General Pharmaceuticals Limited is a mature, small sized company, Pomanda has estimated its turnover at £642k with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded General Pharmaceuticals Limited a 1.5 rating. We use a traffic light system to show it exceeds the industry average on 2 measures and has 9 areas for improvement. Company Health Check FAQs

Health Rating1.5out of 5

2 Strong

1 Regular

9 Weak

Size

annual sales of £642k, make it smaller than the average company (£25.1m)

Growth

3 year (CAGR) sales growth of -39%, show it is growing at a slower rate (5.6%)

EXPORT

General Pharmaceuticals Limited's latest turnover from April 2024 is estimated at £642 thousand and the company has net assets of -£23.5 thousand. According to their latest financial statements, General Pharmaceuticals Limited has 2 employees and maintains cash reserves of £23.7 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Turnover	642,015	885,349	1,059,883	2,819,547	2,898,132	1,987,216	4,638,371	3,046,225	2,105,258	5,329,803	4,000,831	5,068,636	3,554,113	1,365,215	1,178,771
Other Income Or Grants
Cost Of Sales	553,636	763,984	926,476	2,476,310	2,524,555	1,732,280	4,080,070	2,700,326	1,826,425	4,563,589	3,524,723	4,487,716	3,183,433	1,222,160	1,051,858
Gross Profit	88,379	121,366	133,407	343,237	373,578	254,936	558,301	345,899	278,833	766,214	476,108	580,920	370,680	143,055	126,913
Admin Expenses	267,302	334,860	574,343	350,009	464,626	-256,736	191,225	134,972	274,225	972,061	854,422	525,369	-389,033	121,409	114,620
Operating Profit	-178,923	-213,494	-440,936	-6,772	-91,048	511,672	367,076	210,927	4,608	-205,847	-378,314	55,551	759,713	21,646	12,293
Interest Payable							26,518	35,247	10,139
Interest Receivable	2,300	3,762	424	144	572	3,711	759	222	757	910	2,679	3,192	1,198	884	373
Pre-Tax Profit	-176,623	-209,732	-440,512	-6,628	-90,476	515,383	341,316	175,902	-4,773	-204,937	-375,635	58,743	760,912	22,530	12,667
Tax						-97,923	-64,850	-33,421				-13,511	-182,619	-5,858	-3,547
Profit After Tax	-176,623	-209,732	-440,512	-6,628	-90,476	417,460	276,466	142,481	-4,773	-204,937	-375,635	45,232	578,293	16,672	9,120
Dividends Paid
Retained Profit	-176,623	-209,732	-440,512	-6,628	-90,476	417,460	276,466	142,481	-4,773	-204,937	-375,635	45,232	578,293	16,672	9,120
Employee Costs	154,346	152,013	137,050	130,433	119,391	122,148	121,619	108,249	132,231	252,279	206,518	202,027	165,770	78,635	78,194
Number Of Employees	2	2	2	2	2	2	2	2	3	6	5	5	4	2	2
EBITDA*	-170,491	-202,931	-428,281	29,371	-53,228	558,884	371,585	210,927	8,961	-201,658	-374,009	60,934	763,028	23,172	14,306

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Tangible Assets	28,797	30,787	37,968	48,096	79,530	105,553	6,647	11,156	15,675	16,754	17,224	21,529	9,944	4,579	5,610
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets	28,797	30,787	37,968	48,096	79,530	105,553	6,647	11,156	15,675	16,754	17,224	21,529	9,944	4,579	5,610
Stock & work in progress	23,422	23,700	80,807	110,598	368,337	199,134	45,023	27,107	70,149	58,100	54,700	49,225	42,500	46,155	4,463
Trade Debtors	171,464	321,795	405,690	1,260,897	976,586	654,911	1,690,926	1,060,613	522,369	1,437,881	1,171,161	1,255,889	1,122,275	291,637	286,605
Group Debtors
Misc Debtors					540,589	130,699	698,366	1,152,950	648,609
Cash	23,693	63,942	113,077		288,465	855,005	134,528	168,890	8,771	294,202	69,966	1,001,617	275,018	204,361	149,301
misc current assets
total current assets	218,579	409,437	599,574	1,371,495	2,173,977	1,839,749	2,568,843	2,409,560	1,249,898	1,790,183	1,295,827	2,306,731	1,439,793	542,153	440,369
total assets	247,376	440,224	637,542	1,419,591	2,253,507	1,945,302	2,575,490	2,420,716	1,265,573	1,806,937	1,313,051	2,328,260	1,449,737	546,732	445,979
Bank overdraft								815,945	311,961
Bank loan
Trade Creditors	270,868	287,093	274,679	616,216	1,205,765	772,304	1,976,160	1,300,608	817,384	1,738,092	1,039,269	1,678,843	845,552	520,840	436,759
Group/Directors Accounts
other short term finances
hp & lease commitments
other current liabilities					161,586	178,983	116,311	97,610	72,156
total current liabilities	270,868	287,093	274,679	616,216	1,367,351	951,287	2,092,471	2,214,163	1,201,501	1,738,092	1,039,269	1,678,843	845,552	520,840	436,759
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities					76,153	93,536
provisions
total long term liabilities					76,153	93,536
total liabilities	270,868	287,093	274,679	616,216	1,443,504	1,044,823	2,092,471	2,214,163	1,201,501	1,738,092	1,039,269	1,678,843	845,552	520,840	436,759
net assets	-23,492	153,131	362,863	803,375	810,003	900,479	483,019	206,553	64,072	68,845	273,782	649,417	604,185	25,892	9,220
total shareholders funds	-23,492	153,131	362,863	803,375	810,003	900,479	483,019	206,553	64,072	68,845	273,782	649,417	604,185	25,892	9,220

	Apr 2024	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Operating Activities
Operating Profit	-178,923	-213,494	-440,936	-6,772	-91,048	511,672	367,076	210,927	4,608	-205,847	-378,314	55,551	759,713	21,646	12,293
Depreciation	8,432	10,563	12,655	36,143	37,820	47,212	4,509		4,353	4,189	4,305	5,383	3,315	1,526	2,013
Amortisation
Tax						-97,923	-64,850	-33,421				-13,511	-182,619	-5,858	-3,547
Stock	-278	-57,107	-29,791	-257,739	169,203	154,111	17,916	-43,042	12,049	3,400	5,475	6,725	-3,655	41,692	4,463
Debtors	-150,331	-83,895	-855,207	-256,278	731,565	-1,603,682	175,729	1,042,585	-266,903	266,720	-84,728	133,614	830,638	5,032	286,605
Creditors	-16,225	12,414	-341,537	-589,549	433,461	-1,203,856	675,552	483,224	-920,708	698,823	-639,574	833,291	324,712	84,081	436,759
Accruals and Deferred Income				-161,586	-17,397	62,672	18,701	25,454	72,156
Deferred Taxes & Provisions
Cash flow from operations	-36,107	-49,515	115,180	-207,747	-537,932	769,348	807,343	-313,359	-584,737	227,045	-934,330	740,375	78,138	54,671	156,450
Investing Activities
capital expenditure	-6,442	-3,382	-2,527	-4,709	-11,797	-146,118		4,519	-3,274	-3,719		-16,968	-8,680	-495	-7,623
Change in Investments
cash flow from investments	-6,442	-3,382	-2,527	-4,709	-11,797	-146,118		4,519	-3,274	-3,719		-16,968	-8,680	-495	-7,623
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities				-76,153	-17,383	93,536
share issue															100
interest	2,300	3,762	424	144	572	3,711	-25,759	-35,025	-9,382	910	2,679	3,192	1,198	884	373
cash flow from financing	2,300	3,762	424	-76,009	-16,811	97,247	-25,759	-35,025	-9,382	910	2,679	3,192	1,198	884	473
cash and cash equivalents
cash	-40,249	-49,135	113,077	-288,465	-566,540	720,477	-34,362	160,119	-285,431	224,236	-931,651	726,599	70,657	55,060	149,301
overdraft							-815,945	503,984	311,961
change in cash	-40,249	-49,135	113,077	-288,465	-566,540	720,477	781,583	-343,865	-597,392	224,236	-931,651	726,599	70,657	55,060	149,301

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for general pharmaceuticals limited. Get real-time insights into general pharmaceuticals limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for general pharmaceuticals limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in W12 area or any other competitors across 12 key performance metrics.

GENERAL PHARMACEUTICALS LIMITED group structure

General Pharmaceuticals Limited has no subsidiary companies.

Ultimate parent company

GENERAL PHARMACEUTICALS LIMITED

05019416

GENERAL PHARMACEUTICALS LIMITED Shareholders

mrs gloria tokatly	50%
mr ziad tokatly	50%

General Pharmaceuticals Limited currently has 2 directors. The longest serving directors include Mr Ziad Tokatly (Jan 2004) and Ms Gloria Tokatly (Apr 2016).

officer	country	age	start	end	role
Mr Ziad Tokatly	United Kingdom	50 years	Jan 2004	-	Director
Ms Gloria Tokatly	United Kingdom	45 years	Apr 2016	-	Director

P&L

April 2024

turnover

642k

-27%

operating profit

-178.9k

gross margin

13.8%

+0.42%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2024

net assets

-23.5k

-1.15%

total assets

247.4k

-0.44%

cash

23.7k

-0.63%

net assets

Total assets minus all liabilities

Similar Companies

zelens limited

3.5

abbott healthcare products ltd

dasapharm limited

mensana pharma ltd.

3.5

flamingo pharma (uk) ltd

company number

05019416

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

January 2004

ultimate parent company

None

previous names

N/A

address

32 woodstock grove, shepherds bush, london, W12 8LE

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to general pharmaceuticals limited. Currently there are 2 open charges and 0 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for GENERAL PHARMACEUTICALS LIMITED. This can take several minutes, an email will notify you when this has completed.

general pharmaceuticals limited Company Information

general pharmaceuticals limited Estimated Valuation

general pharmaceuticals limited Estimated Valuation

general pharmaceuticals limited Estimated Valuation

General Pharmaceuticals Limited Overview

General Pharmaceuticals Limited Health Check

GENERAL PHARMACEUTICALS LIMITED financials

general pharmaceuticals limited Credit Report and Business Information

General Pharmaceuticals Limited Competitor Analysis

general pharmaceuticals limited Ownership

general pharmaceuticals limited directors

general pharmaceuticals limited company details

general pharmaceuticals limited Charges & Mortgages

general pharmaceuticals limited Capital Raised & Share Issues BETA

general pharmaceuticals limited Companies House Filings - See Documents